1.91 USD
↘ 0.09 (4.50%)AT CLOSE (03:59 PM EDT)
Genelux Corporation Common Stock
GNLXNASDAQ • USD
1.94
↗ 0.03 (1.57%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
1.94
↗ 0.03 (1.57%)
Market: CLOSED
GNLX is currently priced at $1.90. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Furthermore, GNLX is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Oct 26, 2026.
Open?$2.00
High?$2.12
Low?$1.87
Prev. Close?$2.00
Volume?494.7K
Avg. Volume?312.1K
VWAP?$1.96
Rel. Volume?1.59x
Bid / Ask
Bid?$1.63 × 100
Ask?$2.30 × 100
Spread?$0.67
Midpoint?$1.96
Valuation & Ratios
Market Cap?90.5M
Shares Out?45.2M
Float?38.3M
Float %?85.3%
P/E Ratio?N/A
P/B Ratio?5.62
EPS?-$0.79
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.
Themes
Address
2625 TOWNSGATE ROAD, SUITE 230
WESTLAKE VILLAGE, CA 91361
Phone: 805-267-9889
WESTLAKE VILLAGE, CA 91361
Phone: 805-267-9889
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?23
Short Sent.?43
Piotroski F-Score?0/9Weak
Altman Z-Score?-14.83Distress
Confidence?57%Low
Short InterestVery High
Short % of Float?12.14%High
Short Interest?4.6M
Days to Cover?15.7
Free Float38.3M
Avg Daily Volume295.5K
Settlement Date2026-10-15
Financial Health
Current Ratio?2.39Strong
Quick Ratio?2.39Strong
Cash Ratio?1.15Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?5.62FAIR▾
Peers100
S&P33
P/S?11,311.33HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-2.2CHEAP▾
S&P97
EV/Sales?10,163.33HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-220.9%WEAK▾
S&P3
ROA?-135.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-28683000
Enterprise Value?$81.3M
Fundamentals ratios updated end of day